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Background In Argentina, with the aim of moving to a safe supportive and
inclusive National Blood System, in September 2015 the Ministry of Health stipu-
lated that eligibility criteria for blood donation should only take into account the
so-called ’risk practices’, focusing on a ’gender-neutral’ policy. The aim of this
study is to demonstrate the impact of such regulation on the prevalence of STI in
the population of blood donors in Argentina, through the analysis of the scien-
tific evidence obtained from 174 074 donors from a large central region of the
country, focused on a regional Blood Bank for a 6-year period (pre- and post-en-
try into force of the regulations).
Materials and Methods To analyse the evolution of prevalence rates of STI, two
periods of 3 years each were evaluated: The first period (P1) lasted from 16
September 2012 to 15 September 2015 (prior to the entry into force of the law)
and the second one (P2) from 16 September 2015 to 15 September 2018 (after
the entry into force of the law).
Results A total of 82 838 subjects were enrolled in P1 and 91 236 in P2. The
results show a significantly lower prevalence of HCV (P = 0029), HBV
(P = 0028) and syphilis (P = 0001) in P2, while no difference was observed for
HIV infection (P = 060).
Conclusion This study evidenced that the implementation of a ’gender-neutral’
policy based on individual risk-assessment deferral criteria maintained the safety
of blood supply and decreased the prevalence of STI among blood donors.
Key words: blood donor deferral, men who have sex with men, sexually transmit-
ted infections, transfusion-transmitted infections.
Introduction
Donor eligibility criteria for men who have sex with men
(MSM) are under continuous evaluation. Based on epi-
demiological and scientific evidence, debates on this topic
focus on the maintenance of current levels of safety and
reduction of HIV transmission risk, to ensure adequate
quality of blood supplies [1].
Currently, in several countries, blood donor eligibility
criteria regarding MSM have been reformed and deferral
policies in many jurisdictions are nowadays based on a
period of abstinence from MSM, while in other countries,
they are based on donor sexual activities considered of
high risk [2]. Nevertheless, there are changes to indefinite
deferral policies, but not all countries have changed this
policy [3]. Nowadays, in Australia, MSM are deferred
from blood donation when the risky behaviour occurred
within the previous 12 months [4]. However, the Aus-
tralian Red Cross Blood Service is now attempting to
shorten this deferral period to 6 months, as the Japanese
Red Cross has recently done [2]. In the same direction, in
* Correspondence: Sebastian Blanco, Laboratorio de Biologıa Molecular,
Fundacion Banco Central de Sangre, Caseros 1576, Cordoba, Cordoba
5000; Argentina
E-mail: seba_36@hotmail.com or sblanco@fcm.unc.edu.ar
1
2001, the criteria for blood donor eligibility in Italy were
changed from permanent deferral of MSM to individual
risk assessment of sexual behaviour [5]. In December
2015, the U.S. Food and Drug Administration (FDA)
released revised guidelines regarding deferral criteria for
MSM blood donors, changing its policy from indefinite
deferral to a 12-month postponement since the last sexual
contact with another man [6]. In this sense, time-based
deferrals have been already reduced from 12 months to 4
in the Netherlands, Denmark and France and to 3 months
in England, Scotland, Wales and Canada [7,8].
In Argentina, with the aim of moving to a safe, sup-
portive and inclusive National Blood System, in Septem-
ber 2015, the Argentinean Ministry of Health released a
regulation ruling that selection criteria of the National
Blood System for blood donors should rely on a paradigm
shift replacing the category ’risk group’ for ’risk situation’
[9]. The new donor eligibility criteria should only take
into consideration the so-called ’risk practices’, focusing
in a ’gender-neutral’ policy. In this sense, the 2015 regu-
lation established that ’the incorporation of information
regarding diverse situations and/or sexual practices con-
sidered of “high risk” in the donor selection process, pro-
pitiating the self-exclusion and/or professional
consultation in case of doubt, is considered more ade-
quate than a deep investigation regarding sexual orienta-
tion or gender identity’ [9]. Thus, the legislation
recognizes that sexual orientation does not determine the
risk of acquiring an infection but risky situations, like
unprotected sexual practices, do. Therefore, blood donor
deferral criteria are based on individual risk assessment to
identify any personal behaviour that could make the
donor interviewer suspect a risk for sexually transmitted
infections (STI) that could be transfusion-transmitted (TTI)
as well. Prior to this regulation, the blood donor selection
criteria established a 12-month deferral for MSM without
inquiring about the safety of their sexual practices. This
represents a paradigm shift in the Argentinean transfu-
sion medicine, since the so extended practice that
excluded MSM just because of their sexual orientation,
gender identity or expression was rejected. Nowadays, the
question about having sex with MSM has been excluded
from the situations that involve a 12-month deferral [9].
Also, donor interviews have to avoid questioning about
sexual orientation. Following this change, the current
attention focuses on those situations that could increase
the risk of acquiring TTI, no matter the sexual prefer-
ences.
The aim of this report is to show the impact of the new
regulation on the prevalence of STI in the population of
blood donors in Argentina, through the analysis of scien-
tific evidence obtained from 174 074 donors from a large
central region of the country and focused on a regional
Blood Bank during a 6-year period (pre- and post-entry
into force of the regulations).
Materials and methods
To analyse the evolution of prevalence rates for STI, two
periods of three years each were analysed: the first period
(P1) lasted from 16 September 2012 to 15 September
2015 (prior to the entry into force of the law) and the
second one (P2) from 16 September 2015 to 15 September
2018 (after the entry into force of the law). Prevalence
rates for TTIs are donation-based.
The study was developed in a blood bank of Cordoba,
a large province of Argentina. This Blood Bank central-
izes different blood transfusion services (BTSs) working
all over the 165 321 km2 of the province. Serological and
molecular pre-transfusion screenings of almost 50% of
the blood units collected throughout the province are per-
formed in this centre. Thus, the donor population of this
blood bank is not circumscribed to a particular area but
distributed in a large region of the centre of the country;
Cordoba province is the second most populated region of
Argentina.
Blood donors´ data were obtained from the Blood Bank
Information System. Personal information regarding sex,
age, personal identification number (PIDN), current resi-
dence, status of replacement or altruistic/repeat donor,
donor qualifications or clinical data, pre- or post-dona-
tion self-exclusion and serological/molecular studies was
recorded in the database system and analysed. Even when
a unique database number was assigned for every indi-
vidual donation, donors PIDN allowed to link multiple
donations and discriminate between first-time/repetitive
donations. Blood donors are classified as repeat donors if
they had donated blood at least three times during the
same year without evidence of previous blood donations,
or when they had donated blood at least once in the last
12 months and had previous altruistic donations within
the last 24 months. Replacement donors were those who
were required to give blood urgently for a relative or
close friend.
In both periods, potential donors filled a questionnaire
to collect any relevant information about epidemiological
features, clinical conditions and any practice that would
place them at risk of carrying TTIs. With the purpose of
avoiding discrepancies between BTSs and confusion in
blood donors, in Argentina, donor selection is standard-
ized by the Plan Nacional de Sangre of the Ministry of
Health of Argentina. Compelling with that, all blood
banks use the same documents for donor qualifications:
donor information form, pre-donation self-exclusion doc-
ument, personal questionnaire and post-donation self-ex-
clusion documents, which are available for free on the
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web and can be downloaded from the government web-
site (see reference [9]).
The candidates were face-to-face interviewed by
trained healthcare personnel, who decided if they were
eligible to donate blood according to the donor selection
criteria defined by the active law.
Serological screening of blood donors was performed
as follows: detection of antigens and antibodies against
HIV (HIV Ag/Ab, Abbott, Wiesbaden, Germany) by
chemiluminescence assay (ARCHITECT HIV Ag/Ab combo
reagent kit, Abbott), detection of antibodies against HCV
by anti-HCV (anti-HCV reagent kit ARCHITECT, Abbott,
Wiesbaden, Germany), detection of HBsAg (ARCHITECT
AgHBs reagent, Abbott, Sligo, Irland) and anti-core
(ARCHITECT core reagent kit, Abbott, Wiesbaden, Ger-
many) and detection of antibodies to Treponema pallidum
(ARCHITECT Syphilis TP, Abbott, Wiesbaden, Germany).
By protocol, all reactive samples are retested from the
primary tube and the donation bag sample. Furthermore,
a second sample is obtained from reactive donors for
retesting.
Cordoba province has effective regulations that estab-
lish the compulsory use of NAT at regional level, making
it mandatory for all blood banks in the province since
2010, based on Decree N° 1047/ Resolution N° 618 [10].
NAT was introduced in our blood bank in 2006 [11].
Molecular screening of all blood donors was performed
with COBAS TaqScreen MPX Version 2.0 test (Roche
Molecular Systems, Cobas Taqscreen MPX: Roche Diag-
nostics GmbH, Mannheim, Germany) for detection of
HIV-1 RNA Group M, HIV-1 Group O RNA, HIV-2 RNA,
HCV RNA, and HBV DNA in minipools of six. Samples
included in reactive minipools are afterwards tested indi-
vidually to identify the reactive one.
By protocol, when a sample results repeatedly reactive
by serology and molecular tests, a second sample is
requested from the donor to confirm the identity of the
primary sample. When only NAT is reactive, a careful fol-
low-up is performed to confirm infection.
Statistical analysis
Chi-squared test was applied to investigate any correla-
tion between prevalence rates and sex or period of study.
The statistical package R version 3.2.4 software (R Core
Team) was used for statistical analyses. In all cases, sig-
nificance level was 5%.
Results
Demographic data and the evolution of prevalence rates
for STI were analysed, and results are shown in Tables 1
and 2, respectively. Total numbers of donors enrolled in
P1 were 82 838 and 91 236 in P2. Age distribution and
standard deviation between the two periods were identical
(36 – 11 years), and the proportion of donors by gender
in both periods was similar (Table 1). Proportion of first-
time/repeat donors was 80%/20% for P1 and 77%/23%
for P2, respectively. These proportions are concordant
with those reported for Cordoba by the provincial blood
programme authorities (Visintın G. personal communica-
tion, June 14, 2019).
The results show a significantly lower prevalence for
HCV (P = 0029), HBV (P = 0028) and syphilis
(P = 0001) in P2, while no changes were observed for
HIV infection (P = 0605).
Rates of infection were compared among female donors
showing absence of significant variations for HIV
(P = 0165), HBV (P = 0427), HCV (P = 0084) or syphilis
(P = 0151) between both periods (Table 2). On the other
hand, comparison among male donors revealed that while
rates did not vary significantly for HIV (P = 0155), there
was a significantly lower prevalence for HCV (P = 0045),
HBV (P = 0006) and syphilis (P = 0001) in P2 (Table 2).
In P1, donors who tested HIV or HCV positive by NAT
were also positive by serology while five male donors
tested HBV positive only by NAT. In P2, donors who
tested positive for HBV by NAT were also positive by
serology, including one male and one female with recent
infections (Reactive HBV NAT and HBsAg and nonreac-
tive anti-core) while two serological window periods
(SWP), one for HCV and other for HIV, were detected by
NAT.
Results for SWP and recent infections detected in P1
and P2 were confirmed by complementary assays and/or
sero-conversion of donors by follow-up. All of them were
first-time replacement donors.
Discussion
Herein, we demonstrate the effectiveness of the paradigm
shift from ’risk group’ to ’risk practice’. We investigated
the rates of STI in an Argentinean blood donor popula-
tion before and after the implementation of the manda-
tory regulation of the Healthy Ministry, which introduced
a ’gender-neutral’ individual risk-practice deferral policy.
The comparison of STI rates obtained through six years
in this survey shows that donor selection criteria focusing
on identification of individual risk practices allowed to
defer those who were not eligible based on high risk of
TTI, preserving the safety of blood supply.
Deferral donor criteria based on the risk-group model
undermines the right of access to health care and is not a
good model in terms of sustainability of the blood supply
system. Moreover, it promotes discrimination because in
a ’risk-group’ paradigm-based model, some people cannot
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donate or may feel forced to lie in order to donate blood.
Besides, a model based on the concept of ‘risk group’
establishes a 12-month deferral for MSM without inquir-
ing about the safety of sexual practices. It has been
demonstrated that the risk should be assessed individually
rather than impute a risk status just because of the mem-
bership of specific groups [7]. In this sense, although HIV
prevalence is higher in homosexual men, this fact does
not determine that a MSM is certainly infected.
Last decades, evidence-based studies supporting MSM
deferral policies based on individual risk assessment have
been disclosed. In a study by Seed et al. [4], the authors
did not find any evidence that the implementation of a
12-month deferral for MSM resulted in an increased risk
for blood transmission of HIV in Australia. Recently, a
review by Haire et al. [7], also in Australia, concluded
that the reduction of the deferral period to 3 months does
not increase the risks of HIV transmission. Moreover, a
study by Suligoi et al. [5] in 2013 demonstrated that after
the change of donor screening criteria introduced in Italy
in 2001, no significant increase in the proportion of MSM
compared to heterosexuals was observed among HIV anti-
body-positive blood donors. Modelling studies performed
in the US, Canada, UK and France evaluating several sce-
narios predicted negligible risk increments (less than 1 in
1 million units) when changing to a 12-month deferral
period [2,8].
Even though our data are in agreement with the men-
tioned reports [2,4-5,7,8], local epidemiological context is
complex and different. In this sense, during recent years,
there has been an increase in the incidence of STI.
According to a report released in December 2018 by the
Ministry of Health of Argentina, the rate of syphilis cases
in young people and adults tripled between 2013 and
2017 [12]. This rate has been growing steadily, reaching
its highest growth in 2018 with a rate of infection of
511 people per 100 000 inhabitants (Fig. 1) [13]. Like-
wise, the rate of syphilis positivity in pregnant women
increased from 2% to 32% between 2013 and 2017[12]
reaching 4% during 2018 [13] (Fig. 2). Like for blood
donors, syphilis screening is mandatory in pregnant
women, but through a nontreponemal test. The yearly
comparison of syphilis rates between both populations
(Fig. 2) evidences a decrease in the incidence of this
infection in donors. Considering this particular scenario,
the lower prevalence of syphilis demonstrated in this
Table 1 Blood donor demographic data
Age Sex (%) Type of donor (%)
Median Mean Standard Deviation Male Female First Time/ Replacement Repeat
P1 35 36 –11 66 34 80 20
P2 36 36 –11 63 37 77 23
Table 2 HIV, HBV, HCV and Syphilis prevalence rates in a blood donor population of Argentina
STI Period 1 (n = 82 838) Period 2 (n = 91 236) P valuea
HIV 69 (0084%)b 70 (0076%)b 0605
M 60 (87%) 55 (79%) 0155
F 9 (13%) 15 (21%) 0165
HBV 44 (0.053%)e 29 (0031%)b 0028
M 38 (86%) 22 (76%) 0006
F 6 (14%) 7 (24%) 0427
HCV 45 (0055%)b 30 (0033%)b 0029
M 27 (60%) 18 (60%) 0045
F 18 (40%) 12 (40%) 0084
Syphilis 1539 (186%)b 1514 (166%)b 0001
M 1060 (69%) 1030 (68%) 0001
F 469 (31%) 486 (32%) 0151
F, female donors; M, male donors; STI, sexually transmitted infections.
a
Independent chi-squared test. In all cases, significance level was 5%.
b
Reactive donors.
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study during P2 reveals the great importance of individ-
ual risk assessment to identify risk practices in blood
donors. Moreover, along with this fact, we demonstrated
a significant decrease of other STI as HBV and HCV dur-
ing P2. In this regard, in a previous publication, our
group reported the usefulness of NAT in the reduction of
the risk of HBV transmission with a frequency of 1 in
56 072 [11]. We also found a high frequency of HBV
recent infections (1/33 643) [11]. Herein, we are commu-
nicating the detection of 5 SWP for HBV infections in P1
and 2 HBV recent infections in P2, which is concordant
with the significantly lower prevalence of STI found in
P2.
On the other hand, the SWP for HCV and HIV detected
in P2 reflects the current epidemiological context of the
country. In this regard, the increase in syphilis rates in
the general population and pregnant women during
recent years in Argentina is a direct indicator of an
increase in risky sexual practices, which has direct impact
on the acquisition of other STI. Thus, despite the higher
rates expected for these pathogens in regional blood
banks, the lower prevalence detected for syphilis, HCV
and HBV, especially the lower frequency of HBV recent
infections, during P2 reinforce the fact that current donor
selection measures based on individual risk factors mini-
mize the risk of acquiring TTI. This solid evidence
demonstrates that deferral of blood donors should not be
based on donor sexual identity or orientation but on the
assessment of individual risk practices. A time deferral
for MSM without inquiring about sexual practices rein-
forces stigma and their exclusion is not scientifically jus-
tified. For this reason, we agree with the concept that
sexual orientation does not determine the risk of acquir-
ing an infection; however, engagement in risky situations,
like unprotected sex, does.
It is necessary to reinforce gender-neutral deferral pol-
icy with the use of highly sensitive techniques. It has
been already discussed that WP for blood-borne infec-
tions should be taken into account in the calculation of
deferral period [7,8]. In Argentina, only Cordoba province
has effective regulations that establish the compulsory
use of NAT, making it mandatory for all blood banks in
the province [10,11]. The introduction of NAT testing for
all blood donations in Cordoba by Ministerial regulation
occurred after transmission of HIV during SWP to two
recipients in 2008. Until 2007, there were at least six tri-
als with final judgement in Argentina related to transfu-
sion-transmitted HIV during SWP. Although there is not
national regulation, different blood banks across the
country have already incorporated NAT into regular pre-
transfusional screening. Our findings demonstrate that it
would be necessary to promote unified effective regula-
tions in order to set up the compulsory use of NAT
throughout the country.
Scientific evidence provided herein, along with preexist-
ing information reported in other countries [2,4-5,7,8],
support the feasibility of a system based on a ’gender-neu-
tral’ deferral and the paradigm shift from ’risk group’ to
’risk practice’, which is more extensive and inclusive. Fur-
thermore, based on the rates yielded by our survey, we can
assure that the change from time-based deferral policies to
strategies based on individual risk assessment does not
compromise transfusion safety and reduces the risk of STI
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Fig. 1 Evolution of syphilis rates in the Argentinean general population (2005–2018). Data provided by the National Health Surveillance System (Sistema
Nacional de Vigilancia de Salud, SNVS), published in the Bulletin on HIV, AIDS and STIs in Argentina N°36 by the Ministry of Health, 2019 [13].
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Unlike estimations expressed by Haire et al. [7], we are
convinced that it is responsibility of the Blood Depart-
ment to conduct probing and intimate questioning on
sexual practice since individual face-to-face donor inter-
view is critical to exclude donations from individuals at
risk of TTI, but also provides an opportunity to educate
and motivate people to become regular responsible
donors. A sustainable and responsible blood donation
system must ensure that donors engaged in sexual prac-
tices with high risk for STI are capable to identify the risk
themselves and refrain from donating blood. Studies on
unreported deferrable risk among donors demonstrate that
the personal perception of risk is key to non-compliance
with donor selection criteria [3]. Inadequate level of
awareness of risk behaviour in the blood donor popula-
tion has already been discussed [5]. Thus, education of
the potential blood donor population is a key to generate
blood donors with self-perception of the risks, understood
as the ability to identify exposure to factual unsafe prac-
tices.
Finally, we are convinced that based on the principle
that ’nobody contracts or transmits an infection because of
what he/she is, but for what he/she does’, harmonization
of deferral criteria for all donors regardless sexual identity
allows to maintain the safety of blood supply. In this
sense, we are sure that the key formula to achieve sustain-
able and inclusive blood supply systems is to continue
working to train specialists in identifying individual risk
practices in the blood donor population. This, in addition
to the education of the general population, would ensure
safe and sufficient supply of blood and blood products
from responsible donors for future generations.
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